Evidence map›Paper›PMID 31817476›Full record

ArticlePolymers2019

Long-Lasting Examinations of Surface and Structural Properties of Medical Polypropylene Modified with Silver Nanoparticles.

Magdalena Ziąbka, Michał Dziadek

Abstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Magdalena ZiąbkaDepartment of Ceramics and Refractories, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.ORCID 0000-0003-0702-7137
Michał DziadekDepartment of Glass Technology and Amorphous Coatings, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 30-059 Krakow, Poland.ORCID 0000-0001-5661-5467

Funding

the National Centre for Research and Development LIDER/ 154/L-6/14/NCBR/2015
6 · The paper itself

Abstract

Composite materials based on polypropylene modified with silver nanoparticles (PP/AgNPs) were manufactured using injection molding and extrusion. Two different matrices were used to prepare the samples consisting of 0.5 and 1.0 wt. % of silver nanoparticles, respectively. The aim of this study was to assess whether silver nanoparticles (AgNPs) could influence the stability of a polymer matrix during the 24-month period of the in vitro testing. The results indicated that composites with silver nanoparticles displayed the significantly higher Young modulus and tensile strength after the first and second year of investigation. Moreover, the incorporation of nanoparticles into the matrix slightly increased the roughness and contact angle values and the parameters remained stable after the in vitro incubation. The two-year immersion of materials in the deionized water proved that the microstructure of composites did not change. The DSC analysis revealed that the material incubation resulted in a slight reduction in the melting temperature and degree of crystallinity of PP. The addition of nanoparticles to polymer matrices led to the increase in content of β crystals in the crystalline phase of PP, which was revealed in the long-term in vitro tests. The XRD measurement also showed the heightened surface crystallinity. The conducted studies have proved that all composites are stable over a period of 24 months. Such behavior suggests that the tested materials can be used as biomaterials.

Indexed as

compositespolypropylenesilver nanoparticlessurface and structural properties

Identifiers

PMID31817476
PMCPMC6960924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.